Pharmacokinetic analysis for the differentiation of pituitary microadenoma subtypes through dynamic contrast-enhanced magnetic resonance imaging.

In conclusion, Ktrans and Kep derived from DCE-MRI could be applied to detect and identify microadenoma subtypes. Ktrans better reflects the blood perfusion alterations exhibited by patients with different microadenoma subtypes. PMID: 30944618 [PubMed]

https://www.ncbi.nlm.nih.gov/pubmed/30944618?dopt=Abstract

Source: Oncology Letters - April 5, 2019 Category: Cancer & Oncology Tags: Oncol Lett Source Type: research